肌萎缩
肝硬化
肝细胞癌
医学
发病机制
疾病
重症监护医学
生物信息学
干预(咨询)
肝病
慢性肝病
内科学
生物
护理部
作者
Paolo Gallo,Marianna Silletta,Antonio De Vincentis,Federica Lo Prinzi,Francesca Terracciani,Giuseppina Di Fazio,Valentina Flagiello,Umberto Vespasiani Gentilucci,Raffaele Antonelli Incalzi,Antonio Picardi
出处
期刊:Chemotherapy
[S. Karger AG]
日期:2021-12-31
卷期号:67 (3): 152-163
被引量:12
摘要
Sarcopenia is almost constantly observed in patients with cirrhosis and hepatocellular carcinoma (HCC).Chronic liver disease represents a unique pathophysiological scenario in which sarcopenia develops and all factors involved in the pathogenesis should be taken into account for an appropriate management of the disease. No properly designed intervention studies on this topic are available and, thus, no effective strategies have been developed for clinical practice. Apart from any targeted intervention, treatment, and optimization of liver disease is crucial.In patients with cirrhosis and HCC, nutritional support to maintain and restore nutrition status, a targeted use of branched-chain amino acids and a guided physical exercise, should all be an integral part of the multidimensional assessment and tailored interventions.
科研通智能强力驱动
Strongly Powered by AbleSci AI